# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Vaxart (VXRT) shares surged 23% in premarket session after receiving a $453 million project award from BARDA to conduct a COVID...
Gross proceeds to Vaxart from the offering are expected to be $40 million, before deducting underwriting discounts and commissi...
Initial $65.7M For Study Start-Up; Remaining $387.2M Pending Further Study Approval; Enrollment Expected Summer 2024, Interim A...
Palo Alto Networks reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.25 by 5.6%. Q...